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Background: Arginine methylation is a post-translational modification that expands the functional diversity of
proteins. Kinetoplastid parasites contain a relatively large group of protein arginine methyltransferases (PRMTs)
compared to other single celled eukaryotes. Several T. brucei proteins have been shown to serve as TbPRMT
substrates in vitro, and a great number of proteins likely to undergo methylation are predicted by the T. brucei
genome. This indicates that a large number of proteins whose functions are modulated by arginine methylation
await discovery in trypanosomes. Here, we employed a yeast two-hybrid screen using as bait the major T. brucei
type I PRMT, TbPRMT1, to identify potential substrates of this enzyme.
Results: We identified a protein containing N-LIP and C-LIP domains that we term TbLpn. These domains are
usually present in a family of proteins known as lipins, and involved in phospholipid biosynthesis and gene
regulation. Far western and co-immunoprecipitation assays confirmed the TbPRMT1-TbLpn interaction. We also
demonstrated that TbLpn is localized mainly to the cytosol, and is methylated in vivo. In addition, we showed that,
similar to mammalian and yeast proteins with N-LIP and C-LIP domains, recombinant TbLpn exhibits phosphatidic
acid phosphatase activity, and that two conserved aspartic acid residues present in the C-LIP domain are critical for
its enzymatic activity.
Conclusions: This study reports the characterization of a novel trypanosome protein and provides insight into its
enzymatic activity and function in phospholipid biosynthesis. It also indicates that TbLpn functions may be
modulated by arginine methylation.
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Arginine methylation is a post-translational modification
whose importance and widespread impact has recently
begun to be fully appreciated [1-4]. In yeast and mammals,
arginine methylation has been associated with a diver-
sity of cellular processes including signal transduction
[5,6], RNA transport [7,8] and processing [9-12], protein
localization [13-15], and transcription [16]. The effects
of arginine methylation on these processes are exerted
primarily through the modulation of protein-protein and,
less often, protein-nucleic acid interactions [17-20]. Com-
mon sites of arginine methylation within proteins include
RGG, RG, or RXR motifs [21-23], although methylation of
arginine also occurs within other sequence contexts [24].
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reproduction in any medium, provided the orof enzymes termed protein arginine methyltransferases
[PRMTs). While these enzymes are apparently absent
from prokaryotes, putative PRMTs have been identified
in the genomes of all eukaryotes examined with the
exception of Giardia lamblia [1,25,26].
PRMTs are classified into four types. Both type I and II
PRMTs catalyze the formation of ω-NG monomethy-
larginine (MMA). Type I enzymes subsequently synthesize
ω-NG,NG asymmetrical dimethylarginine (ADMA), while
the type II enzymes form ω-NG,N’G symmetrical
dimethylarginine (SDMA). Type III and type IV enzymes
catalyze the formation of only ω-NG monomethylarginine
(MMA) or δ-NG monomethylarginine, respectively. In
humans, nine PRMTs have been confirmed, most of them
being type I enzymes [3]. In contrast to what has been de-
scribed in humans, only three PRMTs have been described
in Saccharomyces cerevisiae, one each of type I type II,
and the apparently fungal-specific type IV [1]. Mostl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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PTMTS, are predicted to possess at least one type I and
one type II PRMTs [26].
Trypanosoma brucei is a parasitic protozoan and the
causative agent of African sleeping sickness in humans
and nagana in African livestock. The genome of T. brucei
predicts the presence of five PRMTs [26], a relatively large
number for a single celled organism [1]. These PRMTS,
with the exception of the putative type I TbPRMT3, have
previously been characterized. TbPRMT1 is the major
type I PRMT in T. brucei, analogous to its role in yeast
and mammals [27]. TbPRMT5 is a type II enzyme ho-
mologous to human PRMT5 [28]. TbPRMT7 is a novel,
kinetoplastid-specific type III PRMT [29]. Finally, the
recently characterized TbPRMT6 is a type I PRMT cap-
able of automethylation [30]. To date, only a few argin-
ine methylproteins have been reported in T. brucei.
These include the mitochondrial RNA binding proteins
RBP16, TbRGG1, TbRGG2, and MRP2. The effects of
RBP16 methylation have been characterized. RBP16 is a
TbPRMT1 substrate, as shown by in vitro methylation
assays and the hypomethylated state of RBP16 in
TbPRMT1 knockdown cells [31]. Arginine methylation
affects the ability of RBP16 to stabilize specific mitochon-
drial RNAs and exerts both positive and negative impacts
on the interaction of RBP16 with different classes of RNAs
and ribonucleoprotein complexes [18,31]. In addition, a
large number of proteins harboring arginine/glycine rich
regions likely to undergo methylation are predicted by the
T. brucei genome, and several T. brucei RNA binding pro-
teins serve as TbPRMT substrates in vitro [26-29,32]. This
indicates that a large number of proteins whose functions
are modulated by arginine methylation await discovery in
trypanosomes.
To gain insight into functions of arginine methyla-
tion in trypanosome gene regulation, we set out to
identify substrates of the major T. brucei type I PRMT,
TbPRMT1. We performed a yeast two-hybrid screen
using the entire TbPRMT1 open reading frame as bait,
exploiting the propensity of PRMTs to associate in a
relatively stable manner with their substrates [33].
Using this approach, we identified a protein containing
two conserved domains found in a family of proteins
known as lipins. Lipins are involved in adipocyte develop-
ment and phospholipid biosynthesis in mammalian and
yeast cells. We termed this protein TbLpn. While these
two domains, known as N-LIP and C-LIP domains, are
found in several mammalian and yeast lipin proteins
[34,35], TbLpn possesses no homology to known proteins
outside these two domains and is, thus, a kinetoplastid-
specific protein. Consistent with the yeast-two-hybrid
data, we show that TbLpn interacts in vivo with
TbPRMT1, and that it is methylated on arginine resi-
dues in vivo. We also show that, as predicted by thepresence of conserved domains, TbLpn displays phospha-
tidic acid phosphatase activity in vitro, and that the two
conserved aspartic acid residues present in the C-LIP
domain, are essential for enzymatic activity.
Results
Identification of TbLpn as a TbPRMT1-interacting protein
To begin to understand the functions of protein argin-
ine methylation in trypanosomes, we sought to identify
proteins that interact with the major type I PRMT in
T. brucei, TbPRMT1. PRMTs tend to associate in a
relatively stable manner with their substrates, and several
mammalian methylproteins have been identified through
protein-protein interaction screens with PRMTs [36,37].
To identify TbPRMT1-interacting proteins, we screened a
yeast-two-hybrid library comprised of mixed procyclic
(PF) and bloodstream form (BF) T. brucei cDNA [38]
using the entire TbPRMT1 ORF as bait. Approximately
800 colonies that grew under moderate selection on SD
medium (−Trp, -Leu, -His) were selected for more strin-
gent screening on SD medium (−Trp, -Leu, -His, -Ade).
One of the colonies isolated from this screen
contained a 1,071-nucleotide insert, which we identified
as a fragment of T. brucei gene Tb927.7.5450 (http://
www.genedb.org) (Figure 1A). The predicted protein
encoded by this gene contains an N-LIP domain at its
amino terminus, as well as a C-LIP domain extending
from amino acid 441–593. These 2 domains are found
in a family of proteins known as lipins (Figure 1B).
Lipin-1, the first member of this family, was identified
in the mouse by positional cloning of the mutant gene
responsible for fatty liver dystrophy (fld) [39]. In
addition, the fld mice also exhibit hypertriglyceridemia,
increased susceptibility to atherosclerosis, insulin resist-
ance, and peripheral neuropathy [39-41]. Lipin proteins
are present in organisms from a wide evolutionary
spectrum, including protozoa, yeast, Drosophila, fish, and
mammals (Figure 1B) [39,42-45]. TbLpn homologues can
be identified in other trypanosome genomes such as
Trypanosoma cruzi and Leishmania major, and these pro-
teins display between 32–43.5% amino acid identity with
TbLpn [46]. The members of the lipin family serve two
major cellular functions: as an enzyme necessary for
phospholipid and triacylglycerol biosynthesis, and as a
transcriptional cofactor involved in the regulation of lipid
metabolism genes [34]. In addition, lipin homologues have
been shown to play an essential role in nuclear membrane
biogenesis in yeast [47].
To begin to characterize TbLpn, we amplified the
complete predicted ORF from PF cDNA. Sequence analysis
revealed six nucleotide differences from the Tb927.7.5450
sequence reported in GeneDB, three of which result in
amino acid changes (Glu-157→Gly-157, Lys-675→
Thr-675, Val-715→Ala-715). The predicted TbLpn
Figure 1 TbLpn sequence analysis. A) Shown is the predicted amino acid sequence of TbLpn. The region shown to interact with TbPRMT1 by
yeast-two hybrid analysis is shown in italics. The N-LIP and C-LIP domains are boxed. The conserved DxDxT domain is shown in bold. B) A
schematic representation of TbLpn amino acid sequence aligned with members of the lipin family is shown in the left panel. The degree of
amino acid sequence identity between TbLpn and members of the lipin family is shown on the right panel. TbLpn [T. brucei, (Tb), accession
number AAX78871], Lipin-1 [Human, (Hs), AAH30537], Lipin-2 [Human, (Hs), AAI52449], Lipin-3 [Human (Hs), CAI42978], Lipin-1 [Mouse, (Mm),
NP_766538], Lipin-2 [Mouse (Mm), AAH39698], Lipin-3 [Mouse (Mm), EDL06298], Lipin-M [Drosophila melanogaster, (Dm), NP_001188884], Lipin-1
[Danio rerio, (Dr), AAX19945], Smp2 [Saccharomyces cerevisiae, (Sc), BAA00880].
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predicted molecular mass of 86.7 kDa. The N-LIP do-
main of TbLpn displays 30–37.5% amino acid identity
with the corresponding domains from lipin proteins
(Figure 1B and Figure 2A). In addition, the C-LIP domain
of TbLpn exhibits 46-50% amino acid identity with the
corresponding domains from members of lipin family,
such as mammalian lipin-1, lipin-2, lipin-3, and yeast
Smp2 (Figure 1B and Figure 2B). Most interesting, the
motif (DXDXT) shown to confer phosphatidic acid phos-
phatase activity to mammalian and yeast lipins, is present
within the C-LIP domain of TbLpn (445DVDGT) [43]. In
addition, a conserved glycine residue shown to be essential
for the mouse Lipin-1 function is also present in the
predicted amino acid sequence of TbLpn (Gly-74) [39].
Apart from this domain, no significant homology is ob-
served between TbLpn and other members of the lipin
family. For instance, although lipin proteins share the
LXXIL motif, which has been shown to be essential for
interaction of Lipin-1 with the nuclear cofactors in-
volved in the regulation of fatty acid metabolism, TbLpn
lacks that conserved LXXIL motif, suggesting that
TbLpn might have a different function than other lipins
[48]. Although TbLpn may not possess co-transcriptional
activity, it might still act as a phosphatidic acid phosphat-
ase. In addition, the conserved nuclear localization se-
quence, usually found in almost all species [34], is absent
in TbLpn.Subcellular localization of TbLpn
To determine the subcellular localization of TbLpn, PF
T. brucei cells were fractionated into cytosolic and nuclear
extracts, and the presence of TbLpn within these compart-
ments assessed by western hybridization. The efficiency
of the fractionation procedure was confirmed by using
antibodies directed against cytosolic Hsp70 and nuclear
RNA polymerase II. As shown in Figure 3, a band of the
expected size for TbLpn (~ 83 kDa) was present exclu-
sively in the cytoplasm of the parasite. This is in con-
trast to all previously characterized mammalian and
yeast lipins which display cytoplasmic as well as nuclear
localization [34,39,49-51]. In addition, SMP2, the yeast
lipin homologue, has been shown to be present in the
cytosol as well as associated with the membrane [43].
We did however detect the presence of a protein band
with decreased electrophoretic mobility (~120 kDa) in
the nuclear extract. This strongly suggests that TbLpn
is present in both cytosol and nucleus and, in the nucleus,
is heavily modified by post-translational modifications
such as arginine methylation and/or phosphorylation.
TbLpn interacts with TbPRMT1 in vitro and in vivo
We further confirmed the TbPRMT1/TbLpn interaction
identified by yeast-two-hybrid first by Far Western
hybridization. To this end, recombinant His-TbLpn was
electrophoresed and transferred to PVDF, and the mem-
brane was incubated with recombinant His-TbPRMT1.
Figure 2 Amino acid sequence alignment of TbLpn conserved domains and other lipin family members. A) Amino acid sequence
alignment of N-LIP domains. Sequences were aligned using CLUSTALW. Identical and conserved amino acids are shown in black and grey boxes,
respectively. B) Amino acid sequence alignment of C-LIP domains. Sequences were aligned using CLUSTALW. Identical and conserved amino
acids are shown in black and grey boxes, respectively. The conserved aspartic acid residues shown to be essential for enzymatic activity in yeast
and mammalian lipins are indicated by asterisks (*).
Pelletier et al. BMC Microbiology 2013, 13:101 Page 4 of 11
http://www.biomedcentral.com/1471-2180/13/101Detection of His-TbPRMT1 with polyclonal anti-
TbPRMT1 antibodies revealed the presence of a band
at 105 kDa, which is the predicted size of His-TbLpn,
thereby demonstrating direct binding of His-TbPRMT1 to
His-TbLpn (Figure 4A). As a negative control, His-RBP16,
expressed and purified using the same protocol as for the
purification of His-TbLpn, was used. Using this negative
control, no band was detected. The data indicate that
TbLpn and TbPRMT1 interact directly.
In order to examine the interaction between TbPRMT1
and TbLpn in vivo, we performed a co-immunoprecipitation.
As shown above, TbLpn is located in the cytosol of the
parasite. For this reason, TbLpn was immunoprecipitated
from PF T. brucei cytosolic extracts using purified poly-
clonal anti-TbLpn antibodies. Proteins that were immuno-
precipitated along with TbLpn were separated by
electrophoresis and transferred onto PVDF. The presence
of TPRMT1 in association with TbLpn was determined by
using purified polyclonal anti-TbPRMT1 antibodies to
probe the membrane by western hybridization. The resultsshown in Figure 4B clearly show that a band of approxi-
mately the size of TbPRMT1 (38.9 kDa) co-precipitates
exclusively with TbLpn, and is not present in the negative
control.
TbLpn is methylated in vivo
The physical association of TbPRMT1 with TbLpn sug-
gests that TbLpn may serve as a substrate for methyla-
tion by TbPRMT1. In support of this hypothesis, several
arginine residues throughout the TbLpn sequence are
located within preferred motifs for methylation, such as
RG or RXR. To evaluate whether TbLpn is methylated
in vivo, an immunoprecipitation was performed from
PF T. brucei cytosolic extracts using purified anti-TbLpn
polyclonal antibodies. The presence of methylated arginine
residues was then determined by western hybridization
using anti-mRG polyclonal antibodies. These antibodies
were raised against a peptide containing 7 asymmetric
dimethylarginine residues alternating with 8 glycine resi-
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Figure 3 Analysis of TbLpn subcellular localization. PF T. brucei
were fractionated into cytosolic (C) and nuclear (N) extracts as
described under Material and Methods. The presence of TbLpn was
detected by western hybridization using anti-TbLpn polyclonal
antibodies (1:1,000), followed by goat anti-rabbit IgGs, and signals
detected using chemiluminescence. Efficiency of the fractionation
procedure was assessed by western blot using antibodies against
Hsp70 and RNA polymerase II as cytosolic and nuclear
markers, respectively.
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have been shown to specifically recognize methylated ar-
ginine residues [52]. Using these antibodies to probe the
blot, a protein band was observed at 85 kDa, which is
the predicted size of TbLpn, in the bound but not the
unbound fraction (Figure 5). This clearly indicates that
native TbLpn contains methylated arginine residues.


















Figure 4 TbLpn interacts with TbPRMT1. A) Far western analysis of TbPR
separated on a 10% polyacrylamide gel, transferred to PVDF, and incubated
blot was probed with anti-TbPRMT1 polyclonal antibodies (1:1,000), followe
chemiluminescence. B) In vivo interaction between TbLpn and TbPRMT1. T
using anti-TbLpn polyclonal antibodies as described under Material and Me
the absence of antibodies. Proteins present in the starting cytosolic fraction
separated on a 10% polyacrylamide gel and transferred to PVDF. The prese
membrane with anti-TbLpn polyclonal antibodies (1:1,000), followed by go
complexes was detected by probing the blot with anti-TbPRMT1 polyclona
detected using chemiluminescence.to interact with TbPTMT1 in vivo, suggests that one
or several arginine residues within TbLpn might be
asymmetrically dimethylated by TbPRMT1. Further
experiments are underway to identify the enzyme(s)
responsible for TbLpn methylation.
TbLpn displays phosphatidic acid phosphatase activity
in vitro
Lipin proteins are known to exhibit Mg2+-dependent
phosphatidic acid phosphatase activity, catalyzing de-
phosphorylation of phosphatidic acid (PA) into diac-
ylglycerol. The predicted amino acid sequence of TbLpn
contains two conserved domains found in all lipins. In
addition, two aspartic acid residues that have been
shown to be essential for enzymatic activity of yeast and
mammalian lipins are also found in TbLpn. To deter-
mine whether recombinant TbLpn could catalyze de-
phosphorylation of phosphatidic acid, enzymatic assays
were performed using the substrate 1,2-dioctanoyl-sn-
glycero-3-phosphate (DiC8 PA), Mg2+, and increasing
amount of His-TbLpn. Following incubation at 30°C, the
amount of Pi released was measured by reading the ab-
sorbance at 620 nm following the addition of PiBlue re-
agent. Figure 6 shows that recombinant TbLpn exhibits
phosphatidate phosphatase activity, suggesting that
TbLpn may play a role in the synthesis of phospholipids.
From our data, we calculated that recombinant TbLpn
has a specific activity of 200–225 nmol/min/mg. In con-
trast, the recombinant mutant in which the two conserved
aspartic acid residues (Asp-445, Asp-447) were changed to
alanines (His-DEAD) shows significantly less phosphatase
activity. The calculated specific activity of 11–12 nmol/
min/mg calculated for the mutant protein clearly impliesB
IP:                 No IgGs anti-TbLpn
C          U          B          U           B
WB: anti-TbLpn
WB: anti-TbPRMT1 
MT1-TbLpn interaction. Purified His-TbLpn and His-RBP16 were
with purified TbPRMT1 as described under Material and Methods. The
d by goat anti-rabbit IgGs, and signals detected using
bLpn was immunoprecipitated from PF T. brucei cytosolic extracts
thods. As a negative control, the cytosolic extract was incubated in
(C), as well as the bound (B) and unbound fractions (U) were
nce of TbLpn in the immune complexes was assessed by probing the
at anti-rabbit IgGs. The presence of TbPRMT1 in the immune
l antibodies (1:1,000), followed by goat anti-rabbit IgGs. Signals were
IP:                 No IgGs anti-TbLpn
C         U        B        U       B
WB: anti-TbLpn
WB: anti-mRG
Figure 5 TbLpn is methylated in vivo. TbLpn was immunopurified
from PF T. brucei cytosolic extracts using anti-TbLpn polyclonal
antibodies as described under Material and Methods. As a negative
control, the cytosolic extract was incubated in the absence of
antibodies. Proteins present in the starting cytosolic fraction (C), as
well as the bound (B) and unbound fractions (U) were separated on
a 10% polyacrylamide gel and transferred to PVDF. The presence of
TbLpn in the immune complexes was assessed by probing the
membrane with anti-TbLpn polyclonal antibodies (1:1,000), followed
by goat anti-rabbit IgGs. To determine whether TbLpn contains
methylated arginines, the blot was probed with anti-mRG polyclonal
antibodies (1:1,000) [52], followed by goat anti-rabbit IgGs. Signals
were detected using chemiluminescence.
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enzymatic activity.
Discussion
In an effort to discover trypanosome substrates of PRMTs,
































Figure 6 Recombinant TbLpn displays phosphatidic acid
phosphatase activity. The enzymatic activity was measured by the
release of phosphate from 1,2-dioctanoyl-sn-glycero-3-phosphate
(DiC8 PA). The substrate was incubated with increasing amounts of
either His-TbLpn (black bars) or His-DEAD (white bars) recombinant
proteins. The amount of phosphate released was measured using
PiBlue reagent and recording the absorbance at 620 nm.that associate with the major type I protein arginine
methyltransferase in T. brucei, TbPRMT1 [27]. Of particu-
lar interest to us are proteins whose functions might be af-
fected by arginine methylation. Here, we report that
TbPRMT1 directly interacts in both Far Western and co-
immunoprecipitation assays with a novel protein. We
termed this protein TbLpn, based on the presence of two
conserved (N-LIP and C-LIP) domains found in a family
of proteins called lipins. We further demonstrate that, like
TbPRMT1, TbLpn is cytoplasmic in PF T. brucei, consist-
ent with a function in TbLpn methylation. Together, these
data point to TbLpn as a candidate protein whose post-
transcriptional gene regulatory functions are affected by
arginine methylation.
We demonstrated that, as predicted from the amino
acid sequence, recombinant TbLpn, as other members
of the lipin family, exhibits phosphatidic acid phosphatase
enzymatic activity. Mutation of the conserved aspartic acid
residues (Asp-445 and Asp- 447) to alanines results in a
significant reduction in the enzymatic activity of TbLpn.
These two aspartic acid residues are part of the conserved
DxDxT motif found in lipin proteins and other members
of the haloacid dehalogenase (HAD)-like superfamily
[53,54]. Based on the crystal structure of L-2-haloacid
dehalogenase from Pseudomonas, it is likely that Asp-445
in TbLpn acts as a nucleophile in the phosphoryl transfer
reaction.
Compared to the recombinant yeast PAH1 (3000 nmol/
min/mg) and human Lipin-1 (1,600 nmol/min/mg), His ~
TbLpn displays a lower but still significant specific activity
[43]. One possible explanation for this lower specific activ-
ity is the fact that the recombinant protein may not con-
tain the same post-translational modifications as those
found in the native protein. It is of interest that several
lipin homologues are highly modified at the post tran-
slational level. In rat and in mouse adipocytes, Lipin 1
contains at least 19 and as many as 23 sites that are phos-
phorylated in response to insulin [49,55,56]. Although it
does not affect its intrinsic phosphatidic acid phosphatase
activity, phosphorylation of Lipin-1 decreases the asso-
ciation with intracellular membranes, thus the active
lipin fraction [49]. In addition, the lipin homologue
SMP2 is phosphorylated by the cyclin-dependent kinase
Cdc28/Cdk1 in budding yeast [57]. The authors have
shown that phosphorylation of SMP2 by Cdc28/Cdk1
enhances its association with promoters of lipid bio-
synthetic genes, which leads to their transcriptional
down-regulation. Careful analysis of TbLpn amino acid
sequence revealed the presence of 5 conserved amino
acid residues shown to be phosphorylated in either
mouse (Mm) Lipin-1 or yeast (Sc) Smp2. These residues
are Ser-102 (Ser-110 in Sc), Thr-239 (Thr-282 in Mm),
Thr-255 (Thr-298 in Mm), Ser-282 (Ser-328 in Mm),
and Ser-343 (Ser-392 in Mm). In addition, a previous
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identified TbLpn as containing two phosphorylated resi-
dues (Thr-211 and Ser-221) [58]. Whether additional or
different amino acids are phosphorylated in the PF is still
unclear.
Phosphorylation of TbLpn may also impact its associ-
ation with other proteins, as it has been demonstrated
for at least one other member of the lipin family. In adi-
pocytes, Lipin-1 interacts directly with 14-3-3 proteins
[51]. 14-3-3- proteins are known to regulate the subcel-
lular localization of a wide variety of proteins through
interaction with phosphoserine residues. In adipocytes,
Lipin-1 is mostly localized to the cytosol and translocate
to the endoplasmic reticulum membrane where it cata-
lyzes dephosphorylation of phosphatidic acid. Stimulation
of adipocytes by insulin promotes phosphorylation of
Lipin-1 and enhances binding by 14-3-3 proteins. This
results in cytoplasmic retention of Lipin-1.
Additionally, we showed that TbLpn is methylated on
arginine residues in vivo. To our knowledge, this is the
first instance of any lipin or phosphatidic acid phosphatase
being methylated. The demonstration that TbLpn is meth-
ylated in vivo suggests that methylation could directly
modulate TbLpn enzymatic activity or protein-protein in-
teractions, or both. Arginine methylation has been shown
to generally alter protein function by modulating protein-
protein interactions, protein-nucleic acid interactions, and
protein trafficking [11,21,59,60]. Arginine residues that
serve as substrates for PRMTs are usually found within
glycine/arginine rich (GAR) domains [61-63]. Based on
this, arginine residues throughout TbLpn, including both
the N-LIP and C-LIP domains are predicted to undergo
methylation. Thus, it will be of great future interest to
determine whether TbPRMT1 and/or other TbPRMTs
are responsible for TbLpn methylation in vivo, and to
determine whether TbLpn methylation has any effect
on its ability to interact with other proteins and whether
it modulates its enzymatic activity.
In yeast and mammals, lipin proteins enable the cell to
generate diacylglycerol (DAG) by catalyzing the dephos-
phorylation of phosphatidic acid. In addition to serving as
a precursor for triacylglycerol (TAG), DAG is also used to
synthesize phosphatidylcholine (PC) and phosphatidyleth-
anolamine (PE) [64]. In mammalian and yeast cells, the
bulk of the PC pool is synthesized by the CDP-choline
branch of the Kennedy pathway [64]. In addition, a small
fraction of PC is generated by sequential methylation
of PE [64]. In eukaryotes, PE can be synthesized by
decarboxylation of phosphatidylserine (PS), by head
group exchange with PS, by acylation of lyso-PE, or by
the CDP-ethanolamine branch of the Kennedy pathway
[65,66]. As for other eukaryotes, PC and PE constitute
the majority of phospholipids in trypanosomes [67]. Of
great importance is the fact that, as opposed to otherparasitic organisms, trypanosomes synthesize phospho-
lipids de novo [68]. Although the pathways for phospho-
lipids biosynthesis have not been very well characterized,
recent data have helped to better understand how
trypanosomes are able to assemble phospholipids. In
T. brucei, PC is synthesized solely by the CDP-choline
branch of the Kennedy pathway, while PE is produced
exclusively via the CDP-ethanolamine branch of the
Kennedy pathway [67,69,70]. Disruption of the enzymes
of the CDP-ethanolamine pathway by RNA interference
have shown that this branch of the Kennedy pathway is es-
sential for both procyclic and bloodstream form T. brucei
cell growth [69,71].
PE and phosphatidylinositol (PI) are key phospholipids
involved in the biosynthesis of glycosylphosphatidylinositol
(GPI). In trypanosomes, a large number of surface proteins
with critical role in virulence surface proteins are anchored
to the plasma membrane via GPI molecules. One of these
proteins is the variant surface glycoprotein (VSG), a major
virulence factor that undergoes antigenic variation and en-
ables the parasite to evade the immune system of its mam-
malian host [70]. The steps involved in the biosynthesis of
GPI, a process essential for T. brucei bloodstream form
survival, have been well studied. This synthesis differs in
certain aspects from the pathway in mammalian cells and
yeast. In T. brucei, the pool of PI used for GPI synthesis is
supplied from glucose-6-phosphate by the action of PI
synthase, an enzyme shown to be essential in both blood-
stream and procyclic form trypanosomes [68,70,71]. A
crucial step in the GPI synthesis pathway is the transfer of
phosphoethanolamine (PEtN) to mannose residues on the
growing GPI. In this reaction, the ethanolamine moiety is
provided by PE [72]. As described earlier, synthesis of PE
in T. brucei is carried out via the CDP-ethanolamine
branch of the Kennedy pathway using DAG as the initial
substrate. It has been demonstrated that inhibition of PE
synthesis prevents de novo GPI biosynthesis [73]. As we
demonstrated in the current paper that TbLpn catalyzes
the dephosphorylation of PA into DAG, it is attractive
to speculate that TbLpn plays an important role in GPI
biosynthesis, and thus in the expression of this major
virulence factor.
Conclusion
The results clearly identify TbLpn as a new member of
the lipin family of proteins. The presence of the con-
served N-LIP and C-LIP domains, and especially the
ability of recombinant TbLpn to dephosphorylate phos-
phatidic acid indicate that this enzyme is likely to be in-
volved in phospholipid biosynthesis in trypanosomes.
Finally, the observation that, in vivo, TbLpn contains
methylated arginine residues is very significant, as it is
the only lipin or phosphatidic acid phosphatase to date
to exhibit such a post-translational modification.
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Trypanosome growth
Procyclic form T. brucei brucei clone IsTaR1 stock
EATRO 164 was grown as described in SDM-79 medium
supplemented with 15% fetal bovine serum (FBS) [74].
Identification of TbLpn by yeast two-hybrid screening
For two-hybrid screening, the TbPRMT1 open reading
frame (ORF) was amplified by 35 cycles of PCR from
pMal-TbPRMT1 [27] using primers PRMT1-Y2H/myc-5′
(5′-GCTCTAGACATATGACGGTGGACGCAAATGC
CG-3′) and PRMT-Y2H/myc-3′ (5′-GCGGATCCCTA
TCTAGACCGCAGCCGAAAATCCTGGTC-3′) which
allowed introduction of NdeI and BamHI restriction
sites respectively (underlined). The PCR product was
then cloned into NdeI and BamHI sites of pAS2-1
(CLONTECH Laboratories), and transformed into
Escherichia coli DH5α competent cells (Invitrogen).
The bait plasmid pAS2-TbPRMT1 was co-transformed
into the competent yeast strain AH109, along with a
mixed procyclic and bloodstream form T. brucei cDNA
library (a generous gift from George Cross, Rockefeller
Univ. and Vivian Bellofatto, UMDNJ) cloned into pGADT7
(CLONTECH Laboratories) using the LiAc/PEG method
[75]. Transformed cells were plated onto synthetic dextrose
medium (SD) supplemented with an amino acid dropout
solution lacking histidine (His), leucine (Leu), and trypto-
phan (Trp) and incubated at 30°C. Resultant colonies were
then streaked onto SD medium lacking His, Leu, Trp, and
adenine (Ade). Colonies that grew on this medium were
grown overnight at 30°C in 3 ml of SD broth lacking Leu.
Cells were collected by centrifugation at 14,000 × rpm for
5 min in a Biofuge centrifuge. The pellet was resuspended
in about 50 μl of residual liquid, and 10 μl of a 10 units/μl
lyticase solution was added and thoroughly mixed. Cell
lysis was allowed to proceed at 37°C for 60 min with shak-
ing at 250 rpm. Twenty μl of 10% SDS was then added
and the tube vortexed for 1 min. The samples were then
put to a freeze/thaw cycle (at −20°C) and vortexed one
more time. The plasmid was purified using a GFX DNA
purification column (GE Healthcare) following the manu-
facturer’s instructions, and eluted with 50 μl of deionized
water. Five μl of the purified plasmid was used to trans-
form 20 μl of ELECTROMAX DH10B cells (Invitrogen).
Briefly, electroporation was carried out on ice in 2-mm
cuvettes using a Bio-Rad electroporator with the following
settings: 2,000 V, 25 μF, 200 Ω. Following electroporation,
1 ml of SOC was added and the cells were transferred to a
15-ml snap cap tube, and incubated for 60 min at 37°C
with shaking (250 rpm). Fifty and 500 μl were then plated
onto LB plates containing 0.1 mg/ml ampicillin, and cells
were allowed to grow at least 18 hours at 37°C. Colonies
with pGADT7 containing a DNA fragment were identified
by PCR using primers GAL4AD5′ (5′-CAGGGATGTTTAATACCACTA-3′) and GAL4AD3′ (5′-GCACAGTTG
AAGTGAACTTGC-3′), and sequenced.Production of recombinant TbLpn
C-terminally his-tagged TbLpn was generated as follows.
Total PF cDNA was generated by reverse transcription
primed with [dT]-RXS. The entire TbLpn ORF was ampli-
fied using Deep Vent DNA polymerase (New England
Biolabs), and using oligonucleotides his10-lipin-5′ (5′-CGG
GATCCATGATATCTGGTTTTGCAGATTTC-3′) and
his10-lipin3′ (5′-CCCAAGCTTCCGCTCGAGTCACA
CAGTGTCACCTTGTTGATA-3′) (restriction sites are
underlined) which were constructed based on the genomic
sequence. The PCR product was then digested with
BamHI and XhoI, ligated into the pET26-His10Smt3
expression vector, giving rise to pHis10-TbLpn, and
transformed into E. coli BL21 competent cells (Invitrogen).
A mutant version of TbLpn, in which the two conserved
aspartic acid residues in the DVDGT motif (Asp-445,
Asp-447) are changed to alanine (pHis-TbLpn(DEAD)),
was generated by PCR amplification from pHis10-TbLpn
using the QuikChange II XL™ Site-Directed Mutagenesis





Protein expression was induced with 1 mM isopropyl
β-thiogalactopyranoside (IPTG) and 2% ethanol for 20 h
at 17°C. Cells were resuspended in lysis buffer (10 mM
Tris [pH 8.6], 10 mM glycine, 300 mM NaCl, 10 mM
imidazole, 10% glycerol, 10% ethanol, 4% Tween-20, and
3% Triton X-100) containing 0.05 mg/ml lysozyme, 0.01
mg/ml DNase I, 1 mM phenylmethylsulfonyl fluoride
(PMSF), 1 μg/ml leupeptin, and 1μg/ml pestatin A, and
lysed by 3 freeze/thaw cycles. Each cycle consisted of in-
cubation at 37°C for 15 minutes, followed by incubation
at −80°C for another 15 minutes. The lysed cell suspen-
sion was centrifuged at 17,000 × g for 15 min at 4°C,
and the supernatant was mixed with Probond Ni2+ resin
(Invitrogen) for 12 h at 4°C. The mixture was poured into
a column and the column washed with 40 volumes of
wash buffer (10 mM Tris [pH 7.0], 200 mM NaCl, 30 mM
imidazole, 10% glycerol). His-tagged proteins were eluted
with 10 volumes of wash buffer (pH 6.0) containing
200 mM imidazole.Polyclonal antibody production
Affinity purified polyclonal anti-TbLpn antibodies
were obtained from Bethyl Laboratories, Inc. using
a peptide corresponding to amino acids 791–806
(GLCNTSSENYQQGDTV).
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His-tagged TbLpn was electrophoresed on a denaturing
10% SDS-polyacrylamide gel and transferred onto a
polyvinylidene fluoride (PVDF) membrane at 50 V for 45
min in 10 mM 3-[Cyclohexylamino]-1-propanesulfonic
acid (CAPS) buffer (pH 11.0) containing 10% methanol.
As a negative control, his-tagged RBP16 was expressed as
described [76] and purified using the same protocol used
for the purification of His-TbLpn described above. The
membrane was blocked in TBS buffer containing 5%
nonfat dry milk for 1 hour, washed twice for 5 min in TBS
buffer containing 0.05% Tween-20 (TBS-T), and then
incubated with 0.5-1.0 μg of purified TbPRMT1 [27] in
TBS-T containing 2% nonfat dry milk overnight at 4°C.
After two 15 minute washes in TBS-T, the membrane
was probed with anti-TBPRMT1 polyclonal antibodies
(1:1,000) for 2 hours, washed in TBS-T twice for 15 min,
and incubated with goat anti-rabbit IgGs coupled to
horseradish peroxidase. Reactive proteins were detected
using enhanced chemiluminescence (GE Healthcare).
Preparation and fractionation of trypanosome cellular
extracts
Log-phase PF T. brucei brucei clone IsTaR1 stock EATRO
164 were harvested by centrifugation at 6,090 × g for 10
min at 4°C. Fractionation of trypanosome cellular extracts
was performed as described previously [77]. The integrity
of the cellular compartment was confirmed by using anti-
bodies directed against the cytosolic protein Hsp70 or the
nuclear RNA polymerase II [78].
Immunoprecipitation of TbLpn from T. brucei cytosolic
extracts
As it was previously determined that TbLpn is localized
in the cytosol, immunoprecipitation of TbLpn was
performed using PF form T. brucei cytosolic extracts.
Ten μg of purified anti-TbLpn antibodies or 10 μl of IP
buffer (for mock immunoprecipitations) (20 mM Hepes
[pH 7.9], 150 mM sucrose, 150 mM KCl, 3 mM MgCl2,
0.5% Nonidet- P40, 1 μg/ml of pestatin A, 1 μg/ml of
leupeptin, 5 mM PMSF) were added to 200 μl of cytosolic
extract in a final volume of 300 μl of IP buffer. The sam-
ples were incubated at 4°C for at least 12 h with gentle ro-
tation. Ten μl of Protein A-Sepharose (GE Healthcare)
was then added, and the samples incubated 1 hour at 4°C
with gentle rotation. Immune complexes were recovered
by centrifugation at 3,000 × g for 30 s and washed five
times, each time for 5 min, with 1 ml of IP buffer.
Phosphatidic acid phosphatase assays
The standard reaction contained 50 mM Tris–HCl buffer
(pH 7.5), 1 mM MgCl2, and 0.4 mM 1,2-dioctanoyl-sn-
glycero-3-phosphate (DiC8 PA) (Avanti Polar Lipids) in a
total volume of 50 μl. Reactions were initiated by theaddition of recombinant proteins (50–250 ng), and carried
out in triplicate at 30°C for 30 min. The reaction was
terminated by the addition of 100 μl of PiBlue reagent
(BioAssay Systems), and the color allowed to develop at
room temperature for 30 minute. The absorbance was
measured with a spectrophotometer at 620 nm. The
amount of phosphate produced was quantified from a
standard curve using 0.5–4 nmol of potassium phos-
phate. The reactions were linear with time and protein
concentration. The enzymatic activity was expressed as
the number of pmol of phosphate released per minute.
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